• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自 Salvinorin A 的双价 κ 阿片受体激动剂的研究:呋喃环的杂甲基化降低了亲和力。

Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity.

机构信息

McLean Hospital, Belmont, MA 02478, USA and Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA ; School of Chemistry and Bio21 Institute, University of Melbourne, Parkville 3010, Australia.

Center for Substance Abuse Research and Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA.

出版信息

Beilstein J Org Chem. 2013 Dec 20;9:2916-24. doi: 10.3762/bjoc.9.328.

DOI:10.3762/bjoc.9.328
PMID:24454571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3896271/
Abstract

The recent crystal structure of the κ-opioid receptor (κ-OR) revealed, unexpectedly, that the antagonist JDTic is a bivalent ligand: in addition to the orthosteric pocket occupied by morphinans, JDTic also occupies a distinct (allotopic) pocket. Mutagenesis data suggest that salvinorin A (1) also binds to this allotopic pocket, adjacent to the aspartate residue that anchors the basic nitrogen atom of classical opiates (Asp138). It has been suggested that an H-bond donor appended to 1 might interact with Asp138, increasing affinity. Such a bivalent ligand might also possess altered functional selectivity. Based on modeling and known N-furanylmethyl opioid antagonists, we appended H-bond donors to the furan ring of 1. (Dimethylamino)methyl groups at C-15 or C-16 abolished affinity for κ-OR. Hydroxymethylation at C-16 was tolerated, but 15,16-bis-hydroxymethylation was not. Since allosteric modulators may go undetected in binding assays, we also tested these and other low-affinity derivatives of 1 for allosteric modulation of dynorphin A in the [(35)S]GTPγS assay. No modulation was detected. As an alternative attachment point for bivalent derivatives, we prepared the 2-(hydroxyethoxy)methyl ether, which retained high affinity for κ-OR. We discuss alternative design strategies for linked, fused or merged bivalent derivatives of 1.

摘要

最近κ-阿片受体(κ-OR)的晶体结构出人意料地揭示,拮抗剂 JDTic 是一种双价配体:除了吗啡烷占据的正位口袋外,JDTic 还占据了一个独特的(变位)口袋。突变体数据表明,沙蟾素 A(1)也与这个变位口袋结合,位于锚定经典阿片类药物碱性氮原子的天冬氨酸残基(Asp138)附近。有人提出,附加到 1 上的氢键供体可能与 Asp138 相互作用,增加亲和力。这种双价配体也可能具有改变的功能选择性。基于建模和已知的 N-呋喃甲基阿片类拮抗剂,我们在 1 的呋喃环上附加了氢键供体。C-15 或 C-16 上的(二甲氨基)甲基基团使对 κ-OR 的亲和力丧失。C-16 上的羟甲基化是可以容忍的,但 15,16-双羟甲基化则不行。由于变位调节剂在结合测定中可能无法被检测到,我们还测试了这些和其他低亲和力的 1 衍生物对 [(35)S]GTPγS 测定中 dynorphin A 的变位调节作用。未检测到调节作用。作为双价衍生物的替代连接点,我们制备了 2-(羟乙氧基)甲基醚,它对 κ-OR 保留高亲和力。我们讨论了 1 的连接、融合或合并双价衍生物的替代设计策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/a9087ff21b40/Beilstein_J_Org_Chem-09-2916-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/874e3d58c105/Beilstein_J_Org_Chem-09-2916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/b1fd226bae45/Beilstein_J_Org_Chem-09-2916-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/2eb3a9d897fa/Beilstein_J_Org_Chem-09-2916-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/bda2574e18cc/Beilstein_J_Org_Chem-09-2916-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/db76146ad6f2/Beilstein_J_Org_Chem-09-2916-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/e29e642fd9d9/Beilstein_J_Org_Chem-09-2916-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/5c1d39e44ffa/Beilstein_J_Org_Chem-09-2916-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/a9087ff21b40/Beilstein_J_Org_Chem-09-2916-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/874e3d58c105/Beilstein_J_Org_Chem-09-2916-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/b1fd226bae45/Beilstein_J_Org_Chem-09-2916-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/2eb3a9d897fa/Beilstein_J_Org_Chem-09-2916-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/bda2574e18cc/Beilstein_J_Org_Chem-09-2916-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/db76146ad6f2/Beilstein_J_Org_Chem-09-2916-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/e29e642fd9d9/Beilstein_J_Org_Chem-09-2916-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/5c1d39e44ffa/Beilstein_J_Org_Chem-09-2916-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/894a/3896271/a9087ff21b40/Beilstein_J_Org_Chem-09-2916-g007.jpg

相似文献

1
Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity.源自 Salvinorin A 的双价 κ 阿片受体激动剂的研究:呋喃环的杂甲基化降低了亲和力。
Beilstein J Org Chem. 2013 Dec 20;9:2916-24. doi: 10.3762/bjoc.9.328.
2
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
3
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.新型氟烷基选择性 κ 阿片受体拮抗剂 JDTic 衍生物:设计、合成、药理学和分子模拟研究。
Eur J Med Chem. 2015 Jan 27;90:742-50. doi: 10.1016/j.ejmech.2014.12.016. Epub 2014 Dec 11.
4
Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.选择性 κ 阿片受体拮抗剂诺布啡、GNTI 和 JDTic 对非阿片受体和转运体的亲和力较低。
PLoS One. 2013 Aug 14;8(8):e70701. doi: 10.1371/journal.pone.0070701. eCollection 2013.
5
Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes.解析人κ-阿片受体复合物的构象状态、动力学及结合机制。
J Chem Inf Model. 2014 Aug 25;54(8):2294-308. doi: 10.1021/ci5002873. Epub 2014 Jul 25.
6
Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.Salvinorin A是致幻鼠尾草(Salvia divinorum)的一种活性成分,是一种高效的κ-阿片受体激动剂:结构与功能方面的考量。
J Pharmacol Exp Ther. 2004 Mar;308(3):1197-203. doi: 10.1124/jpet.103.059394. Epub 2004 Jan 8.
7
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.鉴定(3R)-7-羟基-N-((1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基)-1,2,3,4-四氢-3-异喹啉甲酰胺为一种新型强效选择性阿片κ受体拮抗剂。
J Med Chem. 2003 Jul 3;46(14):3127-37. doi: 10.1021/jm030094y.
8
Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.Salvinorin A呋喃环的修饰:κ阿片受体选择性部分激动剂的鉴定。
Bioorg Med Chem. 2009 Feb 1;17(3):1370-80. doi: 10.1016/j.bmc.2008.12.012. Epub 2008 Dec 14.
9
Salvinorin A: allosteric interactions at the mu-opioid receptor.Salvinorin A:μ-阿片受体上的变构相互作用。
J Pharmacol Exp Ther. 2007 Feb;320(2):801-10. doi: 10.1124/jpet.106.113167. Epub 2006 Oct 23.
10
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.关于强效κ阿片受体激动剂Salvinorin A药效基团的研究。
J Med Chem. 2005 Jan 27;48(2):345-8. doi: 10.1021/jm049438q.

引用本文的文献

1
Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.具有偏向性、双靶点、阿片-肾上腺素能连接的化合物可能会提高特异性、降低剂量,并增强激动剂或拮抗剂功能,同时降低耐受性和成瘾风险。
Pharmaceuticals (Basel). 2022 Feb 10;15(2):214. doi: 10.3390/ph15020214.
2
New psychoactive substances of natural origin: A brief review.新型天然来源精神活性物质:简要综述。
J Food Drug Anal. 2017 Jul;25(3):461-471. doi: 10.1016/j.jfda.2017.04.001. Epub 2017 Apr 18.
3
Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.

本文引用的文献

1
Chemotype-selective modes of action of κ-opioid receptor agonists.κ 阿片受体激动剂的化学型选择性作用模式。
J Biol Chem. 2013 Nov 29;288(48):34470-83. doi: 10.1074/jbc.M113.515668. Epub 2013 Oct 11.
2
Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands.A 类 G 蛋白偶联受体 (GPCR) 二聚体和双价配体。
J Med Chem. 2013 Sep 12;56(17):6542-59. doi: 10.1021/jm4004335. Epub 2013 Jun 4.
3
Molecular signatures of G-protein-coupled receptors.G 蛋白偶联受体的分子特征。
呋喃取代的鼠尾草酚A类似物的合成及κ-阿片受体活性
J Med Chem. 2014 Dec 26;57(24):10464-75. doi: 10.1021/jm501521d. Epub 2014 Dec 9.
Nature. 2013 Feb 14;494(7436):185-94. doi: 10.1038/nature11896.
4
Salvinorin B meth-oxy-methyl ether.萨尔维诺灵B甲氧基甲基醚
Acta Crystallogr Sect E Struct Rep Online. 2012 Nov 1;68(Pt 11):o3225-6. doi: 10.1107/S1600536812043449. Epub 2012 Oct 27.
5
Structure of the δ-opioid receptor bound to naltrindole.δ-阿片受体与纳曲吲哚结合的结构。
Nature. 2012 May 16;485(7398):400-4. doi: 10.1038/nature11111.
6
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.阿片肽孤儿受体与肽模拟物复合物的结构。
Nature. 2012 May 16;485(7398):395-9. doi: 10.1038/nature11085.
7
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
8
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.
9
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.12-表萨尔维尼醇 A 及其类似物在 κ 阿片受体上的差异信号转导特性。
Bioorg Med Chem Lett. 2012 Jan 15;22(2):1023-6. doi: 10.1016/j.bmcl.2011.11.128. Epub 2011 Dec 7.
10
Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology.欣快素(herkinorin)是从白屈菜硷(salvinorin A)衍生出来的一种 MOP 受体激动剂,它在大鼠福尔马林试验中的抗伤害作用:μ 阿片受体药理学新概念:来自 μ 阿片受体药理学新概念专题研讨会。
Drug Alcohol Depend. 2012 Mar 1;121(3):181-8. doi: 10.1016/j.drugalcdep.2011.10.026. Epub 2011 Nov 26.